The Journal of Thoracic and Cardiovascular Surgery
Volume 141, Issue 4 , Pages 995-1001 , April 2011

One single dose of histidine–tryptophan–ketoglutarate solution gives equally good myocardial protection in elective mitral valve surgery as repetitive cold blood cardioplegia: A prospective randomized study

  • Bjørn Braathen, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Oslo University Hospital Ullevål, Oslo, Norway
    • ,
  • Anders Jeppsson, MD, PhD

      Affiliations

    • Department of Cardiovascular Surgery and Anesthesia, Sahlgrenska University Hospital, Gothenburg, Sweden
    • Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    • ,
  • Henrik Scherstén, MD, PhD

      Affiliations

    • Department of Cardiovascular Surgery and Anesthesia, Sahlgrenska University Hospital, Gothenburg, Sweden
    • Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    • ,
  • Ole M. Hagen, MD

      Affiliations

    • Department of Cardiothoracic Surgery, Oslo University Hospital Ullevål, Oslo, Norway
    • ,
  • Øystein Vengen, MD, PhD

      Affiliations

    • Department of Cardiothoracic Surgery, Oslo University Hospital Ullevål, Oslo, Norway
    • ,
  • Helena Rexius, MD, PhD

      Affiliations

    • Department of Cardiovascular Surgery and Anesthesia, Sahlgrenska University Hospital, Gothenburg, Sweden
    • Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    • ,
  • Vincenzo Lepore, MD, PhD

      Affiliations

    • Department of Cardiovascular Surgery and Anesthesia, Sahlgrenska University Hospital, Gothenburg, Sweden
    • Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden
    • ,
  • Theis Tønnessen, MD, PhD

      Affiliations

    • Department of Cardiothoracic Surgery, Oslo University Hospital Ullevål, Oslo, Norway
    • University of Oslo, Faculty of Hospital Medicine and Center for Heart Failure Research, Oslo, Norway
    • Corresponding Author InformationAddress for reprints: Theis Tønnessen, MD, PhD, Department of Cardiothoracic Surgery, Oslo University Hospital Ullevål, and University of Oslo, Faculty of Hospital Medicine, Oslo, Norway.

Received 18 March 2010 ,Revised 31 May 2010 ,Accepted 5 July 2010.

References 

  1. Gallandat Huet RC, Karliczek GF, van der Heide JN, Brenken U, Mooi B, van der Broeke JJ, et al. Clinical effect of Bretschneider-HTK and St. Thomas cardioplegia on hemodynamic performance after bypass measured using an automatic datalogging database system. Thorac Cardiovasc Surg. 1988;36:151–156
  2. Remadi JP, Baron O, Roussel C, Bizouarn P, Habasch A, Despins P, et al. Isolated mitral valve replacement with St Jude Medical prosthesis: long-term results: a follow-up of 19 years. Circulation. 2001;103:1542–1545
  3. Mehlhorn U, Sauer H, Kuhn-Regnier F, Sudkamp M, Dhein S, Eberhardt F, et al. Myocardial beta-blockade as an alternative to cardioplegic arrest during coronary artery surgery. Cardiovasc Surg. 1999;7:549–557
  4. Salvador L, Mirone S, Bianchini R, Regesta T, Patelli F, Minniti G, et al. A 20-year experience with mitral valve repair with artificial chordae in 608 patients. J Thorac Cardiovasc Surg. 2008;135:1280–1287
  5. Gebhard MM, Preusse CJ, Schnabel PA, Bretschneider HJ. Different effects of cardioplegic solution HTK during single or intermittent administration. Thorac Cardiovasc Surg. 1984;32:271–276
  6. Liu J, Feng Z, Zhao J, Li B, Long C. The myocardial protection of HTK cardioplegic solution on the long-term ischemic period in pediatric heart surgery. ASAIO J. 2008;54:470–473
  7. Allen BS, Winkelmann JW, Hanafy H, Hartz RS, Bolling KS, Ham J, et al. Retrograde cardioplegia does not adequately perfuse the right ventricle. J Thorac Cardiovasc Surg. 1995;109:1116–1124
  8. Braathen B, Tønnessen T. Cold blood cardioplegia reduces the increase in cardiac enzyme levels compared with cold crystalloid cardioplegia in patients undergoing aortic valve replacement for isolated aortic stenosis. J Thorac Cardiovasc Surg. 2010;139:874–880
  9. Januzzi JL, Lewandrowski K, MacGillivray TE, Newell JB, Kathiresan S, Servoss SJ, et al. A comparison of cardiac troponin T and creatine kinase-MB for patient evaluation after cardiac surgery. J Am Coll Cardiol. 2002;39:1518–1523
  10. Larstorp AC, Lund SC, Tønnessen T, Muller C, Kjeldsen SE, Mangschau A. Scintigraphic demonstration of myocardial perfusion and ischaemia associated with coronary artery bypass grafting. Scand Cardiovasc J. 2006;40:354–362
  11. Braathen B, Vengen OA, Tønnessen T. Myocardial cooling with ice-slush provides no cardioprotective effects in aortic valve replacement. Scand Cardiovasc J. 2006;40:368–373
  12. Aarsæther E, Stenberg TA, Jakobsen O, Busund R. Mechanoenergetic function and troponin T release following cardioplegic arrest induced by St Thomas' and histidine-tryptophan-ketoglutarate cardioplegia—an experimental comparative study in pigs. Interact Cardiovasc Thorac Surg. 2009;9:635–639
  13. Bretschneider HJ. Myocardial protection. Thorac Cardiovasc Surg. 1980;28:295–302
  14. Preusse CJ, Winter J, Schulte HD, Bircks W. Energy demand of cardioplegically perfused human hearts. J Cardiovasc Surg (Torino). 1985;26:558–563
  15. Preusse CJ, Gebhard MM, Bretschneider HJ. Myocardial “equilibration processes” and myocardial energy turnover during initiation of artificial cardiac arrest with cardioplegic solution—reasons for a sufficiently long cardioplegic perfusion. Thorac Cardiovasc Surg. 1981;29:71–76
  16. Fridell JA, Mangus RS, Tector AJ. Clinical experience with histidine-tryptophan-ketoglutarate solution in abdominal organ preservation: a review of recent literature. Clin Transplant. 2009;23:305–312
  17. Beyersdorf F, Krause E, Sarai K, Sieber B, Deutschlander N, Zimmer G, et al. Clinical evaluation of hypothermic ventricular fibrillation, multi-dose blood cardioplegia, and single-dose Bretschneider cardioplegia in coronary surgery. Thorac Cardiovasc Surg. 1990;38:20–29
  18. Fanneløp T, Dahle GO, Salminen PR, Moen CA, Matre K, Mongstad A, et al. Multidose cold oxygenated blood is superior to a single dose of Bretschneider HTK-cardioplegia in the pig. Ann Thorac Surg. 2009;87:1205–1213
  19. Sakata J, Morishita K, Ito T, Koshino T, Kazui T, Abe T. Comparison of clinical outcome between histidine-triptophan-ketoglutalate solution and cold blood cardioplegic solution in mitral valve replacement. J Card Surg. 1998;13:43–47
  20. Savini C, Camurri N, Castelli A, Dell'Amore A, Pacini D, Suarez SM, et al. Myocardial protection using HTK solution in minimally invasive mitral valve surgery. Heart Surg Forum. 2005;8:E25–E27
  21. Arslan A, Sezgin A, Gultekin B, Ozkan S, Akay T, Uguz E, et al. Low-dose histidine-tryptophan-ketoglutarate solution for myocardial protection. Transplant Proc. 2005;37:3219–3222
  22. Careaga G, Salazar D, Tellez S, Sanchez O, Borrayo G, Arguero R. Clinical impact of histidine-ketoglutarate-tryptophan (HTK) cardioplegic solution on the perioperative period in open heart surgery patients. Arch Med Res. 2001;32:296–299
  23. Manning AS, Hearse DJ. Reperfusion-induced arrhythmias: mechanisms and prevention. J Mol Cell Cardiol. 1984;16:497–518
  24. Holman WL, Spruell RD, Vicente WV, Pacifico AD. Electrophysiological mechanisms for postcardioplegia reperfusion ventricular fibrillation. Circulation. 1994;90(5 Pt 2):II293–II298
  25. Gorlach G, Podzuweit T, Borsutzky B, Lohmann E, Dapper F. Factors determining ventricular fibrillation after induced cardiac arrest. Thorac Cardiovasc Surg. 1991;39:140–142
  26. Murrah CP, Ferguson ER, Spruell RD, Holman WL. Arrest duration influences postcardioplegia electrophysiologic recovery and reperfusion arrhythmias. Ann Thorac Surg. 1998;65:1003–1008
  27. Sellevold OF, Berg EM, Levang OW. Procaine is effective for minimizing postischemic ventricular fibrillation in cardiac surgery. Anesth Analg. 1995;81:932–938

 The study was supported by The Ingegerd and Viking Olov Björk Scholarship received by Professor Theis Tønnessen and by Sahlgrenska University Hospital (ALF/LUA grant). Custodiol for this study was a generous gift from NordMedica ApS, Bredgade 41, Copenhagen, Denmark.

 ClinicalTrial.Gov. Protocol ID 2007-001780-30.

 Disclosures: Authors have nothing to disclose with regard to commercial support.

PII: S0022-5223(10)00731-2

doi: 10.1016/j.jtcvs.2010.07.011

The Journal of Thoracic and Cardiovascular Surgery
Volume 141, Issue 4 , Pages 995-1001 , April 2011

Article Tools

* Image Usage & Resolution